SELLAS Life Sciences (SLS) is rated 'Hold' due to pending phase 3 REGAL data for GPS in AML after CR2, a major 2026 catalyst.

Issued on behalf of Starfighters Space, Inc. As the post-ISS era approaches, a handful of public-market operators are ...

Mount Olivet wants to build a brewery and coffeehouse in place of its original church, which would work as a nonprofit in ...

The affordability crisis brings about talk of the price at the gas pump, but more Canadians are realizing the cost climate ...

To address AI bias at its roots, we must understand the human heuristics that shape it. Unlike prior frameworks that focus ...

The study offers a valuable resource and integrates multiple complementary datasets to provide insights into regulatory mechanisms, although the conceptual advances are moderate and the central ...